Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
- Submitting institution
-
The University of Manchester
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 38656065
- Type
- D - Journal article
- DOI
-
10.1016/S0140-6736(15)01129-0
- Title of journal
- The Lancet
- Article number
- -
- First page
- 866
- Volume
- 387
- Issue
- 10021
- ISSN
- 0140-6736
- Open access status
- Out of scope for open access requirements
- Month of publication
- December
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
15
- Research group(s)
-
A - Cancer Sciences
- Citation count
- 84
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- I was involved in study conception and design, data acquisition and analysis and paper drafting, writing and submission.
- Non-English
- No
- English abstract
- -
